IP Library Granted Patent US 10,544,394
Granted Patent B2
US 10,544,394 · App. 14/470,769 · Granted Jan 28, 2020

Method of increasing proliferation of bone marrow mononuclear cells expressing STRO1-

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,544,394
App. No.
14/470,769
Granted
Jan 28, 2020
Kind
B2
Abstract

The present invention relates to methods of enhancing proliferation and/or survival of mesenchymal precursor cells (MPC) and/or progeny derived therefrom in vitro or in vivo comprising exposing the MPC or progeny to SDF-1 or analog thereof. The invention also relates to compositions comprising isolated MPCs or progeny derived therefrom and SDF-1 or analogues thereof. The present invention also relates to using such methods and compositions for ex vivo or in vivo bone formation in mammals.

Claims (10)

1. A method of increasing proliferation of STRO1 dim cells, the method comprising: co-culturing:

a) greater than 5% STRO1 bright multipotent mesenchymal cells isolated from bone marrow mononuclear cells with

b) STRO1 dim cells isolated from bone marrow mononuclear cells

such that proliferation of the STRO1 dim cells is increased,

wherein:

i) the STRO1 bright multipotent mesenchymal cells comprise a plurality of cells expressing VCAM1,

ii) the STRO1 dim cells comprise more committed precursor cell types than the STRO1 bright multipotent mesenchymal cells,

iii) the STRO1 bright cells are more primitive than the STRO1 dim cells, and

iv) the STRO1 bright cells emit at least a four-fold greater fluorescent signal than STRO1 dim cells as determined by FACS analysis.

2. A method as claimed in claim 1 , wherein the STRO-1 dim cells express CXCR4.

Assignments (4)
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jan 2, 2026
From: OAKTREE FUND ADMINISTRATION, LLC, AS AGENT
To: MESOBLAST LIMITED; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
Reel/Frame 074174/0183 →
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT AT REEL/FRAME NO. 45759/0682 Recorded Jul 30, 2025
From: HERCULES CAPITAL, INC., AS AGENT
To: MESOBLAST, INC.
Reel/Frame 072294/0555 →
SECURITY INTEREST Recorded Dec 10, 2021
From: MESOBLAST LIMITED ACN 109 431 870; MESOBLAST UK LIMITED; MESOBLAST, INC. (FORMERLY KNOWN AS ANGIOBLAST, INC.); MESOBLAST INTERNATIONAL SÀRL
To: OAKTREE FUND ADMINISTRATION, LLC
Reel/Frame 058957/0447 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Mar 28, 2018
From: MESOBLAST, INC.
To: HERCULES CAPITAL, INC., AS ADMINISTRATIVE AND COLLATERAL AGENT
Reel/Frame 045759/0682 →